Organ Regeneration pp 267-278

Part of the Methods in Molecular Biology book series (MIMB, volume 1001)

Bioengineered Skin Substitutes

  • Pedro Lei
  • Hui You
  • Stelios T. Andreadis
Protocol

Abstract

Bioengineered skin has great potential for use in regenerative medicine for treatment of severe wounds such as burns or chronic ulcers. Genetically modified skin substitutes have also been used as cell-based devices or “live bioreactors” to deliver therapeutics locally or systemically. Finally, these tissue constructs are used as realistic models of human skin for toxicological testing, to speed drug development and replace traditional animal-based tests in a variety of industries. Here we describe a method of generating bioengineered skin based on a natural scaffold, namely, decellularized human dermis and epidermal stem cells.

Key words

Epidermal stem cells Three-dimensional tissue constructs Keratinocytes Differentiation 

References

  1. 1.
    Medalie DA, Eming SA, Collins ME et al (1997) Differences in dermal analogs influence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation 64:454–465PubMedCrossRefGoogle Scholar
  2. 2.
    Hilal L, Rochat A, Duquesnoy P et al (1993) A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nat Genet 5:287–293PubMedCrossRefGoogle Scholar
  3. 3.
    Jarvikallio A, Pulkkinen L, Uitto J (1997) Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat 10:338–347PubMedCrossRefGoogle Scholar
  4. 4.
    Chamcheu JC, Siddiqui IA, Syed DN et al (2011) Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys 508:123–137PubMedCrossRefGoogle Scholar
  5. 5.
    Khavari PA, Rollman O, Vahlquist A (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252:1–10PubMedCrossRefGoogle Scholar
  6. 6.
    Woodman SE, Lazar AJ, Aldape KD et al (2012) New strategies in melanoma: molecular testing in advanced disease. Clin Cancer Res 18(5):1195–1200PubMedCrossRefGoogle Scholar
  7. 7.
    Meana A, Iglesias J, Del Rio M et al (1998) Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns 24:621–630PubMedCrossRefGoogle Scholar
  8. 8.
    Mansbridge J (2002) Tissue-engineered skin substitutes. Expert Opin Biol Ther 2:25–34PubMedCrossRefGoogle Scholar
  9. 9.
    Liu K, Yang Y, Mansbridge J (2000) Comparison of the stress response to cryopreservation in monolayer and three-dimensional human fibroblast cultures: stress proteins, MAP kinases, and growth factor gene expression. Tissue Eng 6:539–554PubMedCrossRefGoogle Scholar
  10. 10.
    Pinney E, Liu K, Sheeman B et al (2000) Human three-dimensional fibroblast cultures express angiogenic activity. J Cell Physiol 183:74–82PubMedCrossRefGoogle Scholar
  11. 11.
    Healy CM, Boorman JG (1989) Comparison of E-Z Derm and Jelonet dressings for partial skin thickness burns. Burns Incl Therm Inj 15:52–54PubMedCrossRefGoogle Scholar
  12. 12.
    Vanstraelen P (1992) Comparison of calcium sodium alginate (KALTOSTAT) and porcine xenograft (E-Z DERM) in the healing of split-thickness skin graft donor sites. Burns 18:145–148PubMedCrossRefGoogle Scholar
  13. 13.
    Falanga V, Sabolinski M (1999) A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 7:201–207PubMedCrossRefGoogle Scholar
  14. 14.
    Windsor ML, Eisenberg M, Gordon-Thomson C et al (2009) A novel model of wound healing in the SCID mouse using a cultured human skin substitute. Australas J Dermatol 50:29–35PubMedCrossRefGoogle Scholar
  15. 15.
    Burke JF, Yannas IV, Quinby WC Jr et al (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194:413–428PubMedCrossRefGoogle Scholar
  16. 16.
    Yannas IV, Burke JF (1980) Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14:65–81PubMedCrossRefGoogle Scholar
  17. 17.
    Yannas IV, Burke JF, Gordon PL et al (1980) Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14:107–132PubMedCrossRefGoogle Scholar
  18. 18.
    Mostow EN, Haraway GD, Dalsing M et al (2005) Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41:837–843PubMedCrossRefGoogle Scholar
  19. 19.
    Livesey SA, Herndon DN, Hollyoak MA et al (1995) Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. Transplantation 60:1–9PubMedCrossRefGoogle Scholar
  20. 20.
    Cuono C, Langdon R, McGuire J (1986) Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1:1123–1124PubMedCrossRefGoogle Scholar
  21. 21.
    Ramos-e-Silva M, Ribeiro de Castro MC (2002) New dressings, including tissue-­engineered living skin. Clin Dermatol 20:715–723PubMedCrossRefGoogle Scholar
  22. 22.
    Andreadis ST (2004) Gene transfer to epidermal stem cells: implications for tissue engineering. Expert Opin Biol Ther 4:783–800PubMedCrossRefGoogle Scholar
  23. 23.
    Andreadis ST, Hamoen KE, Yarmush ML et al (2001) Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J 15:898–906PubMedCrossRefGoogle Scholar
  24. 24.
    Fentem JH, Botham PA (2002) ECVAM’s activities in validating alternative tests for skin corrosion and irritation. Altern Lab Anim 30(Suppl 2):61–67PubMedGoogle Scholar
  25. 25.
    Tornier C, Rosdy M, Maibach HI (2006) In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Toxicol In Vitro 20:401–416PubMedCrossRefGoogle Scholar
  26. 26.
    Hagino S, Okazaki Y, Itagaki H (2008) An in vitro tier evaluation for the identification of cosmetic ingredients which are not ocular irritants. Altern Lab Anim 36:641–652PubMedGoogle Scholar
  27. 27.
    Roguet R, Cohen C, Dossou KG et al (1994) Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicol In Vitro 8:283–291PubMedCrossRefGoogle Scholar
  28. 28.
    Cotovio J, Onno L, Justine P et al (2001) Generation of oxidative stress in human cutaneous models following in vitro ozone exposure. Toxicol In Vitro 15:357–362PubMedCrossRefGoogle Scholar
  29. 29.
    Kim KH, Chung CB, Kim YH et al (2005) Cosmeceutical properties of levan produced by Zymomonas mobilis. J Cosmet Sci 56:395–406PubMedGoogle Scholar
  30. 30.
    Lelievre D, Justine P, Christiaens F et al (2007) The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol In Vitro 21:977–995PubMedCrossRefGoogle Scholar
  31. 31.
    Chen M, Kasahara N, Keene DR et al (2002) Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 32:670–675PubMedCrossRefGoogle Scholar
  32. 32.
    Choate KA, Medalie DA, Morgan JR et al (1996) Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 2:1263–1267PubMedCrossRefGoogle Scholar
  33. 33.
    Freiberg RA, Choate KA, Deng H et al (1997) A model of corrective gene transfer in X-linked ichthyosis. Hum Mol Genet 6:927–933PubMedCrossRefGoogle Scholar
  34. 34.
    Fakharzadeh SS, Zhang Y, Sarkar R et al (2000) Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. Blood 95:2799–2805PubMedGoogle Scholar
  35. 35.
    Gerrard AJ, Hudson DL, Brownlee GG et al (1993) Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 3:180–183PubMedCrossRefGoogle Scholar
  36. 36.
    Larcher F, Del Rio M, Serrano F et al (2001) A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. FASEB J 15:1529–1538PubMedCrossRefGoogle Scholar
  37. 37.
    Lei P, Ogunade A, Kirkwood KL et al (2007) Efficient production of bioactive insulin from human epidermal keratinocytes and tissue-engineered skin substitutes: implications for treatment of diabetes. Tissue Eng 13:2119–2131PubMedCrossRefGoogle Scholar
  38. 38.
    Tian J, Lei P, Laychock SG et al (2008) Regulated insulin delivery from human epidermal cells reverses hyperglycemia. Mol Ther 16:1146–1153PubMedCrossRefGoogle Scholar
  39. 39.
    Therrien JP, Kim SM, Terunuma A et al (2010) A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin grafts. Proc Natl Acad Sci U S A 107:1178–1183PubMedCrossRefGoogle Scholar
  40. 40.
    Andreadis ST (2006) Experimental models and high-throughput diagnostics for tissue regeneration. Expert Opin Biol Ther 6:1071–1086PubMedCrossRefGoogle Scholar
  41. 41.
    Andreadis ST (2007) Gene-modified tissue-engineered skin: the next generation of skin substitutes. Adv Biochem Eng Biotechnol 103:241–274PubMedGoogle Scholar
  42. 42.
    Geer DJ, Swartz DD, Andreadis ST (2004) In vivo model of wound healing based on transplanted tissue-engineered skin. Tissue Eng 10:1006–1017PubMedGoogle Scholar
  43. 43.
    Geer DJ, Swartz DD, Andreadis ST (2005) Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol 167:1575–1586PubMedCrossRefGoogle Scholar
  44. 44.
    Medalie DA, Eming SA, Tompkins RG et al (1996) Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J Invest Dermatol 107:121–127PubMedCrossRefGoogle Scholar
  45. 45.
    Lugo LM, Lei P, Andreadis ST (2011) Vascularization of the dermal support enhances wound re-epithelialization by in situ delivery of epidermal keratinocytes. Tissue Eng Part A 17:665–675PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Pedro Lei
    • 1
  • Hui You
    • 1
  • Stelios T. Andreadis
    • 1
  1. 1.Department of Chemical and Biological EngineeringUniversity at Buffalo, State University of New YorkAmherstUSA

Personalised recommendations